Literature DB >> 16513670

Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons.

Anton Ivanov1, Christophe Pellegrino, Sylvain Rama, Iryna Dumalska, Yuriy Salyha, Yehezkel Ben-Ari, Igor Medina.   

Abstract

The extracellular signal-regulated kinases (ERK) signalling cascade is a key pathway that mediates the NMDA receptor (NMDAR)-dependent neuronal plasticity and survival. However, it is not clear yet how NMDARs regulate ERK activity. Stimulation of the NMDARs induces a complex modification of ERK that includes both ERK activation and inactivation and depends on particular experimental conditions. Here we show that there exists a differential restriction in the regulation of ERK activity that depends on the pool of NMDAR that was activated. The synaptic pool of NMDARs activates ERK whereas the extrasynaptic pool does not; on the contrary, it triggers a signalling pathway that results in the inactivation of ERK. As a result, simultaneous activation of both extrasynaptic and synaptic NMDAR using bath application of NMDA or glutamate (a typical protocol explored in the majority of studies) produced ERK activation that depended on the concentration of agonists and was always significantly weaker than those mediated by synaptic NMDARs. Since the activation of the extrasynaptic NMDA is attributed mainly to global release of glutamate occurring at pathological conditions including hypoxic/ischaemic insults, traumas and epileptic brain damage, the reported differential regulation of ERK cascade by NMDARs provides a unique mechanism for an early identification of the physiological and/or pathophysiological consequences of NMDAR activation. The negative regulation of the ERK activity might be one of the first signalling events determining brain injury and constitutes a putative target of new pharmacological applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513670      PMCID: PMC1779993          DOI: 10.1113/jphysiol.2006.105510

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  33 in total

1.  Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB.

Authors:  Xuejun Tian; Takaya Gotoh; Kiyoshi Tsuji; Eng H Lo; Su Huang; Larry A Feig
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

2.  Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons.

Authors:  J H Li; Y H Wang; B B Wolfe; K E Krueger; L Corsi; G Stocca; S Vicini
Journal:  Eur J Neurosci       Date:  1998-05       Impact factor: 3.386

3.  Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines.

Authors:  D R Alessi; N Gomez; G Moorhead; T Lewis; S M Keyse; P Cohen
Journal:  Curr Biol       Date:  1995-03-01       Impact factor: 10.834

4.  Stimulation of protein tyrosine phosphorylation by NMDA receptor activation.

Authors:  H Bading; M E Greenberg
Journal:  Science       Date:  1991-08-23       Impact factor: 47.728

5.  Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by stimulation of glutamate receptors.

Authors:  M Kurino; K Fukunaga; Y Ushio; E Miyamoto
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

6.  Magnesium gates glutamate-activated channels in mouse central neurones.

Authors:  L Nowak; P Bregestovski; P Ascher; A Herbet; A Prochiantz
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

7.  PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif.

Authors:  R Pulido; A Zúñiga; A Ullrich
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

8.  Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression.

Authors:  Peter V Massey; Benjamin E Johnson; Peter R Moult; Yves P Auberson; Malcolm W Brown; Elek Molnar; Graham L Collingridge; Zafar I Bashir
Journal:  J Neurosci       Date:  2004-09-08       Impact factor: 6.167

9.  Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase).

Authors:  D M Payne; A J Rossomando; P Martino; A K Erickson; J H Her; J Shabanowitz; D F Hunt; M J Weber; T W Sturgill
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

10.  NR2B-containing receptors mediate cross talk among hippocampal synapses.

Authors:  Annalisa Scimemi; Alan Fine; Dimitri M Kullmann; Dmitri A Rusakov
Journal:  J Neurosci       Date:  2004-05-19       Impact factor: 6.167

View more
  134 in total

1.  Activation of Transient Receptor Potential Vanilloid 4 is Involved in Neuronal Injury in Middle Cerebral Artery Occlusion in Mice.

Authors:  Pinghui Jie; Zihong Lu; Zhiwen Hong; Lin Li; Libin Zhou; Yingchun Li; Rong Zhou; Yebo Zhou; Yimei Du; Lei Chen; Ling Chen
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

2.  Regulation of neuronal gene expression and survival by basal NMDA receptor activity: a role for histone deacetylase 4.

Authors:  Yelin Chen; Yuanyuan Wang; Zora Modrusan; Morgan Sheng; Joshua S Kaminker
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

3.  Deletion of densin-180 results in abnormal behaviors associated with mental illness and reduces mGluR5 and DISC1 in the postsynaptic density fraction.

Authors:  Holly J Carlisle; Tinh N Luong; Andrew Medina-Marino; Leslie Schenker; Eugenia Khorosheva; Tim Indersmitten; Keith M Gunapala; Andrew D Steele; Thomas J O'Dell; Paul H Patterson; Mary B Kennedy
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

4.  Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.

Authors:  Ana Saavedra; Albert Giralt; Laura Rué; Xavier Xifró; Jian Xu; Zaira Ortega; José J Lucas; Paul J Lombroso; Jordi Alberch; Esther Pérez-Navarro
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

5.  In vitro stretch injury induces time- and severity-dependent alterations of STEP phosphorylation and proteolysis in neurons.

Authors:  Mahlet N Mesfin; Catherine R von Reyn; Rosalind E Mott; Mary E Putt; David F Meaney
Journal:  J Neurotrauma       Date:  2012-06-25       Impact factor: 5.269

6.  Neural cell adhesion molecule-associated polysialic acid regulates synaptic plasticity and learning by restraining the signaling through GluN2B-containing NMDA receptors.

Authors:  Gaga Kochlamazashvili; Oleg Senkov; Sergei Grebenyuk; Catrina Robinson; Mei-Fang Xiao; Katharina Stummeyer; Rita Gerardy-Schahn; Andreas K Engel; Larry Feig; Alexey Semyanov; Vishnu Suppiramaniam; Melitta Schachner; Alexander Dityatev
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

7.  Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors.

Authors:  Rashna Balsara; Neill Li; Danielle Weber-Adrian; Louxiu Huang; Francis J Castellino
Journal:  Neuropharmacology       Date:  2012-01-27       Impact factor: 5.250

8.  The Rac1 inhibitor NSC23766 suppresses CREB signaling by targeting NMDA receptor function.

Authors:  Hailong Hou; Andrés E Chávez; Chih-Chieh Wang; Hongtian Yang; Hua Gu; Benjamin A Siddoway; Benjamin J Hall; Pablo E Castillo; Houhui Xia
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

9.  Moderate prenatal alcohol exposure reduces plasticity and alters NMDA receptor subunit composition in the dentate gyrus.

Authors:  Megan L Brady; Marvin R Diaz; Anthony Iuso; Julie C Everett; C Fernando Valenzuela; Kevin K Caldwell
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

10.  Synaptic non-GluN2B-containing NMDA receptors regulate tyrosine phosphorylation of GluN2B 1472 tyrosine site in rat brain slices.

Authors:  Heng Ai; Wen Lu; Mao Ye; Wei Yang
Journal:  Neurosci Bull       Date:  2013-04-13       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.